| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2019-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d0724215f4518f47ed6dc54e3525b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97a9c2ad3d9193af2d54ad7119156410
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e634a4883b4745ef68e6209631d8dfc2 |
| publicationDate |
2020-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200141116-A |
| titleOfInvention |
A Composition for Predicting Response to Tamoxifen |
| abstract |
The present invention relates to a composition for predicting tamoxifen reactivity of a subject against cancer and a method for predicting tamoxifen reactivity using the same. The present invention also relates to a cancer treatment adjuvant composition that significantly enhances the therapeutic effect of tamoxifen. The present invention predicts a patient's therapeutic sensitivity to tamoxifen with high reliability, and can be usefully used to determine the necessity of long-term administration of tamoxifen, which is followed by various side effects due to estrogen receptor inhibition, and ultimately to establish a reasonable treatment strategy. I can. |
| priorityDate |
2019-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |